Marizyme Inc (MARZ) Return on Assets ROA from the third quarter of 2024 to third quarter of 2023 and for the year 2024, Average High and Low, Fundamental Ratios from Sep 30 2024 to Sep 30 2023 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Marizyme Inc   (MARZ)


Marizyme Inc 's ROA from the third quarter of 2024 to the third quarter of 2023 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Marizyme Inc 's ROA in the third quarter of 2024?
Marizyme Inc recorded a cumulative net loss of $-25 million during 12 months ending in the third quarter of 2024, resulting in a negative return on assets (ROA) of -114.92%.

However, within the Healthcare sector 879 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Sep 30 2024 quarter, so far to 4727, from total ROA ranking in the second quarter of 2024 at 4909.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Sep 30 2024)
III. Quarter		 (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter
Y / Y Total Assets Change -42.43 % -44.2 % -43.64 % -43.1 % -41.22 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -25 -49 -78 -75 -89
Return On Assets (TTM) -114.92 % -194.36 % -264.86 % -223.42 % -235.32 %
MARZ's Total Ranking # 4727 # 4909 # 5041 # 5767 # 5211
Total Assets (TTM) in million 21 21 22 22 37
Seq. Total Assets Change 3.01 % -4.33 % -2.02 % -40.37 % -0.17 %
Seq. Net Income Change - - - - -

MARZ's 5 Years Annual ROA >> Back to MARZ Management Effectiveness >> Compare MARZ ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 198
Sector # 880
Overall # 4636

Return On Assets Statistics
High Average Low
-3.7 %
-74.8 %
-279.13 %
(Dec 31 2019)   (Mar 31 2024)





Financial Statements
Marizyme Inc 's Assets $ 21 million MARZ's Balance sheet
Marizyme Inc 's Income $ -2 million Quarterly MARZ's Income Statement
MARZ's Income by Division See MARZ's Income by Division



Annual Return On Assets (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019
Y / Y Total Assets Change -43.1 % -40.93 % 41.17 % 62.13 % 1179.82 %
Total Assets in million 22 39 65 46 29
Y / Y Net Income Change - - - - -
Net Income in million -70 -38 -11 -6 -1
Annual Return On Assets -315.87 % -98.65 % -16.79 % -12.6 % -3.7 %

MARZ's 5 Years Annual ROA >> Back to MARZ Management Effectiveness >> Compare MARZ ROA to its Competitors



More Return On Assets Ratios
MARZ's' Return on Assets at Yahoo Finance
Medical Equipment & Supplies Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
MARZ's Roa Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for MARZ's Competitors
Subscribers only: Roa for Marizyme Inc 's Suppliers
Subscribers only: Return On Assets for MARZ's Customers

You may also want to know
MARZ's Roi MARZ's Inventory Turnover Ratio MARZ's Growth Rates MARZ's Dividend Comparisons
MARZ's Profitability Ratios MARZ's Asset Turnover Ratio MARZ's Dividend Growth
MARZ's Roe MARZ's Valuation Ratios MARZ's Financial Strength Ratios MARZ's Dividend Payout Ratio



Companies with similar Return On Assets at Sep 30 2024, within Healthcare Sector ROA

Date modified: 2026-08-29T17:39:34+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.